深度学习连续QT监测识别Ⅲ类抗心律失常药启用后高危延长事件
研究开发了空间感知深度学习系统3DRECON-QT,从单导联信号重建12导联并预测QT/QTc。在外部测试、多非利特负荷监测和真实植入式心脏监测仪记录中验证了测量准确性。在1676例门诊Ⅲ类抗心律失常药患者中,16.5%存在高危QTc延长,且与室性心律失常事件风险升高相关。
要点
- 3DRECON-QT可从单导联信号准确分类QTc延长,外部测试AUC为0.943。
- 真实植入式心脏监测仪记录中QTc预测r=0.824,平均绝对误差17.5 ms。
- 门诊Ⅲ类抗心律失常药患者中16.5%存在高危QTc延长,与室性心律失常事件风险升高相关。
核心结论
- 单导联深度学习方法可达到指南级测量精度,实现非标准心电向量的连续QTc监测。
- 该方法能识别与严重室性心律失常风险增加相关的门诊QTc延长。
研究设计与样本
- 使用多任务编码器-解码器开发3DRECON-QT,输入10秒单导联信号,重建12导联并预测QT/QTc。
- 模型在大型健康系统的12导联心电图(临床医生裁定QT/RR)上开发,并在不同心电图硬件的外部中心测试。
- 连续监测性能在公共多非利特负荷数据集(系列心电图)中评估。
- 在1676例门诊使用多非利特或索他洛尔的患者中评估室性心律失常和QT延长发生率。
- 在配对植入式心脏监测仪记录与临床12导联心电图的患者中验证设备性能。
主要发现
- 内部测试集中,单导联信号分类QTc延长的AUC为0.942,平均绝对误差17.5 ms。
- 外部测试集中,AUC为0.943,平均绝对误差21.1 ms。
- 连续多非利特监测中,预测与真实值相关r=0.851,平均绝对误差17.8 ms,QTc延长的AUC为0.936,QTc升高≥15%的AUC为0.816。
- 真实植入式心脏监测仪记录的QTc预测r=0.824,平均绝对误差17.5 ms。
- 门诊Ⅲ类抗心律失常药患者中16.5%存在高危QTc延长;室性心律失常事件在有延长者中为3.97%,无延长者为0.86%(调整OR 4.24 [95%CI 1.81-9.90])。
临床怎么用
- 3DRECON-QT可作为Ⅲ类抗心律失常药启用后门诊安全监测的辅助工具,从单导联设备连续监测QTc。
- 识别出的高危QTc延长与室性心律失常风险增加相关,可能支持针对性干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Drug-induced QT prolongation after successful inpatient loading of class III antiarrhythmics may occur during routine outpatient care. Insertable cardiac monitors offer continuous signals but are limited by single-lead configuration. We hypothesized that a spatially aware deep learning system (3DRECON-QT) can reconstruct spatial information from a single lead vector to quantify QT/QTc and identify high-risk prolongation. METHODS: We developed 3DRECON-QT using a multitask encoder-decoder that ingests a 10-s single-lead signal, reconstructs 12 leads, and predicts QT/QTc. The model was developed using 12-lead ECGs with clinician-adjudicated QT/RR from a large health system and tested in an external center with different ECG hardware. Continuous monitoring performance was assessed in a public dofetilide-loading data set with serial ECGs. In a real-world cohort of outpatients on dofetilide or sotalol presenting to the hospital or emergency room for any reason, rates of ventricular arrhythmias and QT prolongation were assessed. Device validation was tested in patients with insertable cardiac monitor recordings paired with clinical 12-lead ECGs. RESULTS: 3DRECON-QT classified prolonged QTc from single-lead signals with area under the receiver operating characteristics curve, 0.942 (mean absolute error, 17.5 ms) in the internal test set and 0.943 (mean absolute error, 21.1 ms) externally. During continuous dofetilide monitoring, predictions correlated with ground truth (r, 0.851; mean absolute error, 17.8 ms; area under the receiver operating characteristics curve, 0.936 for prolonged QTc, 0.816 for ≥15% QTc rise). QTc prediction from true insertable cardiac monitor recordings showed r=0.824 and mean absolute error, 17.5 ms. In outpatients on class III antiarrhythmics (n=1676), 16.5% had high-risk QTc prolongation. Ventricular arrhythmia events were 3.97% versus 0.86% without prolongation (adjusted odds ratio, 4.24 [95% CI, 1.81-9.90]). 3DRECON-QT detected these events with area under the receiver operating characteristics curve 0.94 (F1 score, 0.60). CONCLUSIONS: A single-lead, deep-learning approach can achieve guideline-level measurement accuracy, enable continuous QTc surveillance from nonstandard ECG vectors, and identify clinically meaningful outpatient QTc prolongation associated with a >4-fold increase in serious ventricular arrhythmias. This strategy may enhance safety monitoring after class III antiarrhythmic initiation and support targeted intervention.
引用
- Ansari RA, Bandyopadhyay S, Trivedi RK, et al. Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation. Circulation. 2025. PMID: 41460938. doi:10.1161/CIRCULATIONAHA.125.077494
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。